Nga raau taero hypoglycemic
CAT # | Ingoa Hua | Whakaahuatanga |
CPD0004 | Ertugliflozin | Ko Ertugliflozin, e mohiotia ana ano ko PF-04971729, he aukati kaha me te whiriwhiri mo te konutai-whakaaro glucose cotransporter 2 me te kaitono haumanu mo te maimoatanga o te mate huka momo 2. |
CPDA0048 | Omarigliptin | Ko Omarigliptin, e mohiotia ana ko MK-3102, he aukati DPP-4 kaha me te roa mo te maimoatanga kotahi-wiki mo te mate huka momo 2. |
CPDA1089 | Retagliptin | Ko te Retagliptin, e mohiotia ana ko SP-2086, he aukati DPP-4 ka whakamahia pea mo te maimoatanga o te mate huka Momo 2. |
CPDA0088 | Trelagliptin | Ko te Trelagliptin, e mohiotia ana ko SYR-472, he aukati roa o te dipeptidyl peptidase-4 (DPP-4) e hangaia ana e Takeda mo te maimoatanga o te mate huka momo 2 (T2D). |
CPDA2039 | Linagliptin | Ko Linagliptin, e mohiotia ana ko BI-1356, he aukati DPP-4 i hangaia e Boehringer Ingelheim mo te maimoatanga o te mate huka momo II. |
CPDA0100 | Sitagliptin | Ko te Sitagliptin (INN; i tohuhia i mua ko MK-0431 ka hokona i raro i te ingoa hokohoko Januvia) he antihyperglycemic-waha (taaru mate huka) o te akomanga aukati dipeptidyl peptidase-4 (DPP-4). |
CPD0854 | LX-4211 | Ko te LX-4211 he kaitautoko SGLT2 / 1 ruarua kaha; Nga kaihoko antidiabetic. |
CPDA1553 | LX-2761 | Ko te LX2761 he aukati SGLT1 mahi a-rohe e tino kaha ana i roto i te vitro me te whakaroa i te whakauru huka intestinal i roto i te vivo hei whakapai ake i te mana glycemic. |